Thursday, 02 April 2020

China News

  • MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outsourcing company, have formed a joint venture to develop and commercia...Read more

  • Bal Seal expands in China to tap into growing medical industry

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Responding to predicted growth in China's medical industry, Bal Seal Engineering, a leading provider of custom-engineered sealing, connecting, conducting and EMI shielding compo...Read more

  • APAC ovarian cancer drug market to grow modestly'

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

  • China Botanic reports Q3 2012 results

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Singapore: China Botanic Pharmaceutical revealed its financial results for the three months ending July 31, 2012. During the third quarter (Q3) of fisal year 2012, net revenue increased by ...Read more

  • Golden Meditech Acquires Convertible Notes to Increase Stake in Hospital Management Business

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Golden Meditech Holdings, together with its subsidiaries, a leading integrated healthcare enterprise in China, is increasing its ownership in hospital management business by acq...Read more

  • Research and Markets offers new report on China pharma industry

    China |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: Research and Markets has added a report on China Pharmaceutical Machinery Industry to their offering. This report first gives an overview of the pharmaceutical machinery industr...Read more

  • China Biologics appoint David Gao to additional post of CEO

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    China Biologic Products, one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, has appointed Chairman Mr David (Xiaoying) Gao to the additional pos...Read more

  • BMS pledges $15 million to help curb diabetes in India and China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: The Bristol-Myers Squibb Foundation has expanded its Together on Diabetes initiative to China and India, pledging $15 million over five years to help these developing nations wit...Read more

  • Genetic diagnostics companies speed ahead

    China |  Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013

    The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US Supreme Court on June 13, 2013, stating that human genes cannot be p...Read more

  • Bristol-Myers Squibb reveals new grants for Hepatitis in India, China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 30, 2012: The Bristol-Myers Squibb Foundation has awarded four new grants totaling US $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatiti...Read more

  • Tiyanyin pharma all set for GMP inspection

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more

  • Industry applauds Dr Weidong Yin

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

    "I met Dr Weidong Yin for the first time in 1996 when I went to Tangshan, China. At that time, he was involved in research. He was very young then and was running a very small scale company...Read more

  • Simcere, Zhuhai enter share transfer agreement

    China |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more

  • SFDA reports high chromium in Biostar's drug

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 01, 2012: China based Biostar Pharmaceuticals has acknowledged the finding of  chromium content higher than edible gelatin from a batch of its Xin Aoxing capsules following...Read more

  • US biotech firm invests in China to enter Asia

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 01, 2012: GenScript, a US biotech company, has announced the opening of a new R&D facility in Nanjing, China. This new facility will play a key role in GenScript's strat...Read more

  • Ambrx, Zhejiang, WuXi to develop cancer drug in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2013

    Singapore: US-based Ambrx and China-based Zhejiang Medicine (ZMC) announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally devel...Read more

  • CCBC continues to repurchase shares

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: China Cord Blood, the first and largest cord blood banking operator in China, repurchased an aggregate of 2,191,412 ordinary shares for a total consideration of approximately $6...Read more

  • A great leader'

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2012

    "Dr Wang has great vision for Sundia and her leadership makes it possible for us to see tremendous growth. She has successfully led Sundia to navigate through the global financial crisis in...Read more